These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2217144)

  • 1. Mutational analysis of structure--activity relationships in human tumor necrosis factor-alpha.
    Yamagishi J; Kawashima H; Matsuo N; Ohue M; Yamayoshi M; Fukui T; Kotani H; Furuta R; Nakano K; Yamada M
    Protein Eng; 1990 Aug; 3(8):713-9. PubMed ID: 2217144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel muteins of human tumor necrosis factor alpha.
    Ito R; Matsumoto H; Uchida K; Kubo T; Tsukii Y; Endo T; Kaji A
    Biochim Biophys Acta; 1991 Apr; 1096(3):245-52. PubMed ID: 2018798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-directed mutational analysis of human tumor necrosis factor-alpha receptor binding site and structure-functional relationship.
    Zhang XM; Weber I; Chen MJ
    J Biol Chem; 1992 Nov; 267(33):24069-75. PubMed ID: 1331108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the site on a TNF-alpha molecule which affects type II TNF receptor binding in human cells.
    Ikegami H; Arai N; Moriyasu J; Taniguchi M; Tsusaki K; Honji N; Kohno K; Ando S; Kurimoto M
    Lymphokine Cytokine Res; 1993 Jun; 12(3):173-80. PubMed ID: 7688581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of human tumor necrosis factor-alpha.
    Shin HC; Cho KH
    Biotechnol Lett; 2005 Jan; 27(2):107-12. PubMed ID: 15703873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and expression in Escherichia coli of the gene for mouse tumor necrosis factor.
    Shirai T; Shimizu N; Shiojiri S; Horiguchi S; Ito H
    DNA; 1988 Apr; 7(3):193-201. PubMed ID: 2836146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis factor beta (lymphotoxin).
    Goh CR; Loh CS; Porter AG
    Protein Eng; 1991 Oct; 4(7):785-91. PubMed ID: 1665907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of differentiation of human monoblastic and myeloblastic leukemia cell lines by TNF muteins.
    Kamijo R; Takeda K; Nagumo M; Konno K; Hasegawa A; Inaka K; Ikehara M
    Biochem Biophys Res Commun; 1989 Apr; 160(2):820-7. PubMed ID: 2541714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human tumor necrosis factor mutants: preparation and some properties].
    Shingarova LN; Sagaĭdak LN; Turetskaia RL; Nedospasov SA; Esipov DS; Korobko VG
    Bioorg Khim; 1996 Apr; 22(4):243-51. PubMed ID: 8768260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Woodchuck lymphotoxin-alpha, -beta and tumor necrosis factor genes: structure, characterization and biological activity.
    Li DH; Havell EA; Brown CL; Cullen JM
    Gene; 2000 Jan; 242(1-2):295-305. PubMed ID: 10721723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel muteins of human tumor necrosis factor with potent antitumor activity and less lethal toxicity in mice.
    Kuroda K; Miyata K; Shikama H; Kawagoe T; Nishimura K; Takeda K; Sakae N; Kato M
    Int J Cancer; 1995 Sep; 63(1):152-7. PubMed ID: 7558445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human tumor necrosis factor alpha (TNF alpha) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors.
    Loetscher H; Stueber D; Banner D; Mackay F; Lesslauer W
    J Biol Chem; 1993 Dec; 268(35):26350-7. PubMed ID: 8253759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creation of a high cytotoxic active human tumor necrosis factor having the truncated and more basic amino terminus.
    Guo D; Shen B; Dong X; Qiu Q; Xu X
    Biochem Biophys Res Commun; 1995 Feb; 207(3):927-32. PubMed ID: 7864898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of cytotoxicity of tumor necrosis factor (TNF) by increase in basicity of its N-terminal region.
    Soma G; Kitahara N; Tsuji Y; Kato M; Oshima H; Gatanaga T; Inagawa H; Noguchi K; Tanabe Y; Mizuno D
    Biochem Biophys Res Commun; 1987 Oct; 148(2):629-35. PubMed ID: 3318824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and characterization of receptor-specific TNF muteins.
    Ameloot P; Brouckaert P
    Methods Mol Med; 2004; 98():33-46. PubMed ID: 15064431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and properties of fusion proteins between human interferon-gamma and human tumour necrosis factors alpha and beta.
    Korobko VG; Davydov IV; Shingarova LN; Filippov SA; Esipov DS; Dobrynin VN
    Biomed Sci; 1991; 2(6):634-40. PubMed ID: 1668714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histidine-15: an important role in the cytotoxic activity of human tumor necrosis factor.
    Yamamoto R; Wang A; Vitt CR; Lin LS
    Protein Eng; 1989 May; 2(7):553-8. PubMed ID: 2546145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and expression of the cDNA for canine tumor necrosis factor-alpha in E. coli.
    Zucker K; Lu P; Fuller L; Asthana D; Esquenazi V; Miller J
    Lymphokine Cytokine Res; 1994 Jun; 13(3):191-6. PubMed ID: 7948427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activity of mutants of human tumour necrosis factor-alpha.
    Kircheis R; Milleck J; Korobko VG; Shingarova LN; Behnke D; Schmidt HE
    Immunology; 1992 Jul; 76(3):433-8. PubMed ID: 1526652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the RNA binding proteins forming complexes with a novel putative regulatory region in the 3'-UTR of TNF-alpha mRNA.
    Hel Z; Di Marco S; Radzioch D
    Nucleic Acids Res; 1998 Jun; 26(11):2803-12. PubMed ID: 9592171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.